Fig. 4From: The soluble VCAM-1 level is a potential biomarker predicting severe acute graft versus host disease after allogeneic hematopoietic cell transplantationChanges in the serum sVCAM-1 level according to the time point (days − 7, 0, + 7, and + 14) in relation to allogeneic hematopoietic cell transplantationBack to article page